PUBLISHER: TechNavio | PRODUCT CODE: 1714115
PUBLISHER: TechNavio | PRODUCT CODE: 1714115
The pharmaceutical excipients market is forecasted to grow by USD 5208.9 mn during 2024-2029, accelerating at a CAGR of 7.7% during the forecast period. The report on the pharmaceutical excipients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for functional excipients, growth in pharmaceutical industry, and evolution in techniques used to produce excipients.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 6.6% |
CAGR | 7.7% |
Incremental Value | $5208.9 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's pharmaceutical excipients market is segmented as below:
By Type
By Product
By Route Of Administration
By Form Factor
By Geographical Landscape
This study identifies the demand for new excipients to develop easily consumable drugs as one of the prime reasons driving the pharmaceutical excipients market growth during the next few years. Also, increasing incidence of age-related and other ailments and increasing per capita expenditure will lead to sizable demand in the market.
The report on the pharmaceutical excipients market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical excipients market vendors that include Actylis, Air Liquide SA, Archer Daniels Midland Co., Ashland Inc., Associated British Foods Plc, Avantor Inc., BASF SE, Colorcon Inc., Croda International Plc, DFE Pharma GmbH and Co. KG, Evonik Industries AG, Innophos Holdings Inc., J M Huber Corp., JRS PHARMA GmbH and Co. KG, Kerry Group Plc, Merck and Co. Inc., Roquette Freres SA, The Dow Chemical Co., The Lubrizol Corp., and Wacker Chemie AG. Also, the pharmaceutical excipients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: